Status:
COMPLETED
Retinal Imaging Using NOTAL-OCT V3.0
Lead Sponsor:
Notal Vision Ltd.
Conditions:
AMD
DR
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The study will include up to 250 AMD patients and up to 30 DR patients. In Tel Aviv medical center up to 100 AMD/ 20 DR patients will be recruited; In Assuta HaShalom up to 100 AMD/10 DR patients will...
Detailed Description
4.5.1 SCREENING VISIT: For patients eligible to participate in the study, the following procedure will be done in the screening visit: 1. Patient will sign the IC (Informed Consent) form 2. Test the...
Eligibility Criteria
Inclusion
- 1\. Ability and agreement to give informed consent (IC) 2. Diagnosis of AMD or DR in SE by OCT 3. Ability to undergo OCT scans 4. VA of 20/400 (6/120) or better in study eye(s)
Exclusion
- 1\. Patient with dilated eye(s)
Key Trial Info
Start Date :
December 2 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 26 2023
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT04078672
Start Date
December 2 2019
End Date
March 26 2023
Last Update
June 15 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Assuta Hashalom
Tel Aviv, Israel
2
Tel Aviv Medical Center
Tel Aviv, Israel